Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05238519 · ClinicalTrials.gov registry record · Phase 3
Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)
A Phase 3 study of Genetic Disease and Familial Hypercholesterolemia, sponsored by Essentia Health.
- Active
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT05238519 is a Phase 3 study of Genetic Disease and Familial Hypercholesterolemia that is active but no longer recruiting, run by Essentia Health. The registered enrollment target is 300 participants, below the 2,551-participant average among 30 other Genetic Disease trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05238519, a Phase 3 study of Genetic Disease and Familial Hypercholesterolemia, is active but no longer recruiting, sponsored by Essentia Health.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall goal of this study is to promote awareness of Familial Hypercholesterolemia (FH). The investigators aim to enroll patients with suspected FH into the study and will randomize them to receive usual care or motivational interview. Primary study outcomes include knowledge of FH, as well as clinical and patient-reported outcomes. This study aims to promote optimal disease management and improve outcomes of FH patients.
Conditions Studied
Interventions
- BEHAVIORAL Motivational interview (MI)
Study Locations (2)
Minnesota
- Aspirus St. Luke's Hospital - Duluth
- Essentia Health - Duluth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2026-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05238519
The ClinicalTrials.gov registry entry for NCT05238519 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,551-participant average among 30 other Genetic Disease trials with a reported enrollment target (88% lower). The listed sponsor is Essentia Health, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which Motivational interview (MI) is the first listed.
NCT05238519 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05238519 about?
NCT05238519 is a clinical study titled "Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)". The overall goal of this study is to promote awareness of Familial Hypercholesterolemia (FH). The investigators aim to enroll patients with suspected FH into the study and will randomize them to receive usual care or motivational interview. Primary study outcomes include knowledge of FH, as well as ...
What is the current status of trial NCT05238519?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2022-02-15. Estimated completion is 2026-06.
What conditions does trial NCT05238519 study?
This clinical trial studies the following conditions: Genetic Disease, Familial Hypercholesterolemia, Cholesterol, Elevated.
What interventions are being tested in trial NCT05238519?
The interventions under investigation include: Motivational interview (MI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05238519?
This trial is sponsored by Essentia Health, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05238519 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Long Term Extension Study in Patients With Primary Hyperoxaluria
ACTIVE NOT RECRUITING · Phase 3
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.